Marine biotechnology for human health and personal care
 
To receive periodic e-mail updates of our services, products, and R & D activity please sign-up.
     

GlycoMar is a biotechnology company developing products and services for the human healthcare and personal care markets.

Company Drug Discovery Drug Development Personal Care
GlycoMar is an innovative company investing in pharmaceutical product discovery and the development of platform and enabling technologies to generate valuable intellectual property with opportunities for partnership with the pharmaceutical and personal care sectors.
 
We specialise in discovery of valuable glycobiology products from organisms such as microalgae and invertebrates. Our discovery platform identifies sugar-based glycomolecules(polysaccharides, oligosaccharides, carbohydrates) with therapeutic value and suitable for commercial development.
 
Novel glycomolecule anti-inflammatory candidates are being progressed into preclinical development, both in house and with partner companies, for the treatment of psoriasis and respiratory inflammation.
 
Novel polysaccharides and oligosaccharides are being evaluated for cosmetic development, both in house and with partner companies. These are being developed as natural & ethical active cosmetic ingredients for the skincare market.

 
 

 

 
Glycomar is based at the European Centre for Marine Biotechnology, which is part of the Scottish Marine Institute.
 
You can see what is happening where we are: www.sams.ac.uk/weather